Pfizer and BioNTech failed to clear the Phase 3 hurdle, the companies said Friday. Their shot is a messenger RNA-based vaccine that combines their approved Covid-19 shot, marketed as Comirnaty ...

After receiving his second dose of the Pfizer-BioNTech ... “Never been so excited to get a shot before,” he wrote Jan. 5, sharing a photo of a Band-Aid on his arm and his completed COVID-19 ...

Now, Pfizer and BioNTech say they might need to adjust the vaccine. The companies are discussing their next steps with health authorities. On today's stock market, Pfizer stock dropped 1.4% to 28.30.

Tim Zook’s last post on Facebook brimmed with optimism. “Never been so excited to get a shot before,” he wrote on Jan. 5, above a photo of the Band-Aid on his arm and his COVID-19 ...

A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.

Pfizer and its German partner, BioNTech, announced Friday that their updated coronavirus booster shot targeting the omicron variant succeeded in strengthening the body’s army of disease-fighting ...

Get your shots while they’re on the house: Drug maker Pfizer said Friday that once the Federal government stops footing the bill for COVID-19 vaccines, the cost of a shot will rise to between… ...

The effectiveness of Pfizer and BioNTech’s Covid-19 vaccine in teens fades rapidly in the weeks after vaccination, according to research published Wednesday in JAMA Network Open, a finding that ...

The bivalent shot, dubbed BNT162b5, consists of RNAs that encode enhanced prefusion spike proteins for both the original strain of SARS-CoV-2 and the omicron variant that is prevalent worldwide.

Pfizer’s Price Hike Shot in the Arm for Vaccine Makers. Company’s decision to price its Covid-19 vaccine at $110-$130 per dose seeks to make up for lower demand for boosters. By .